long acting daily insulins
Print Text Size: A A A. On February 25, 2015, the U.S. Food and Drug Administration (FDA) approved the once-daily, long-acting insulin Toujeo (generic name insulin glargine 300 U/ml) for controlling blood glucose in adults with Type 1 and Type 2 diabetes.
(insulin degludec injection 100 U/mL, 200 U/mL) How to start and convert your adult patients to once-daily, long-acting TresibaÂ®.